报告中枢神经系统相关副作用的患者中,抗药物的血总tau度较高
Klara Andersson1, Sarah Akel2, Fredrik Asztély3
1Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden; Department of Neurology, Sahlgrenska University Hospital, member of ERN Epicare, Gothenburg, Sweden; Wallenberg Center of Molecular and Translational Medicine, Gothenburg University, Sweden.
Seizure
|January 18, 2025
概括
血液中总量较高可能表明患者中抗发作药物的中枢神经系统副作用. 需要进一步的研究来确认这是否表明这些药物的脆弱性或危害.
科学领域:
- 神经学 神经学
- 生物标志物 生物标志物
- 的研究研究.
背景情况:
- 中枢神经系统 (CNS) 的副作用在服用抗发作药物 (ASM) 的患者中很常见.
- 目前,缺乏可靠的生物标志物来检测和监测这些ASM诱导的副作用.
- 这项研究探讨了潜在的血基生物标志物对中枢神经系统的副作用.
研究的目的:
- 研究ASM与中枢神经系统相关的副作用与特定脑损伤标志物的血液度之间的关联.
- 确定潜在的生物标志物,用于早期检测和监测中的ASM副作用.
主要方法:
- 一项基于人口的队列研究,涉及来自瑞典神经病学诊所的367名成年患者.
- 分析神经纤维光 (NFL),总tau,质酸纤维蛋白 (GFAP),S100B和神经元特异性酶 (NSE) 的血液度.
- 统计分析包括曼·惠特尼U-测试和多变量逻辑回归,并根据相关临床因素进行调整.
主要成果:
- 报告中枢神经系统副作用的患者的总tau水平明显高于没有中枢神经系统副作用的患者.
- 在调整为多变量回归中的混因素后,这种关联仍然显著.
- 两组之间没有观察到NFL,GFAP或S100B水平的显著差异.
结论:
- 血总 tau 的升高可能与 ASM 中枢神经系统副作用的风险增加有关.
- 长度研究是必要的,以确定高是否反映了患者的脆弱性或ASM的有害影响.
- 总tau显示出作为监测ASM相关的中枢神经系统副作用的生物标志物的潜力.
相关概念视频
01:17Antiepileptic Drugs: Calcium Channel Blockers
299
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
299
01:20Antiepileptic Drugs: Potassium Channel Activators
142
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
142
01:14Antiepileptic Drugs: Glutamate Antagonists
274
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
274
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
230
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
230
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
317
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
317
01:08Antiepileptic Drugs: Sodium Channel Blockers
379
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
379